サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：末期腎不全の世界市場規模：治療法、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1105756

末期腎不全の世界市場規模：治療法、地域別の予測（2022年～2028年）

Global End Stage Renal Disease Market Size study, by Treatment (Transplant, Dialysis) and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
末期腎不全の世界市場規模：治療法、地域別の予測（2022年～2028年）
出版日: 2022年07月12日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糖尿病と高血圧の有病率上昇により、予測期間中に末期腎不全が拡大すると予測されます。

また、技術的に高度な製品の導入が、末期腎不全市場を活性化させる見通しです。さらに、AKIによる病院や入院患者の増加が、予測期間中の市場成長を高めると期待されます。しかし、透析製品に対する厳しい規制政策が、2022年～2028年の間の予測期間中の市場成長を妨げると考えられます。

当レポートでは、世界の末期腎不全市場について調査分析し、市場動向、競合情勢、セグメント別・地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の末期腎不全市場の定義と範囲

第3章 世界の末期腎不全市場力学

  • 末期腎不全市場影響分析（2020年～2028年）

第4章 世界の末期腎不全市場業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の末期腎不全市場：治療法別

  • 市場スナップショット
  • 市場実績・ポテンシャル分析：治療法別
  • 市場推計と予測：治療法別（2018年～2028年）
  • サブセグメント分析
    • 移植
    • 透析

第7章 世界の末期腎不全市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第8章 競合情報

  • 主要な市場戦略
  • 企業プロファイル
    • Medtronic
    • Fresenius Medical Care AG & Co. KGaA
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Asahi Kasei Medical Co., Ltd.
    • Cantel Medical
    • BD.
    • JMS Co. Ltd.
    • Nikkiso Co., Ltd.
    • Nipro Corporation

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global End Stage Renal Disease Market, report scope
  • TABLE 2. Global End Stage Renal Disease Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global End Stage Renal Disease Market estimates & forecasts by Treatment 2018-2028 (USD Billion)
  • TABLE 4. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 5. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 6. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global End Stage Renal Disease Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global End Stage Renal Disease Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. U.S. End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. U.S. End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 16. U.S. End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 17. Canada End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 18. Canada End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 20. UK End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 21. UK End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 23. Germany End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 24. Germany End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 26. RoE End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 27. RoE End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 29. China End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 30. China End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 32. India End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 33. India End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 35. Japan End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 36. Japan End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 38. RoAPAC End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 39. RoAPAC End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 41. Brazil End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 42. Brazil End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 44. Mexico End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 45. Mexico End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 47. RoLA End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 48. RoLA End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 50. Row End Stage Renal Disease Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 51. Row End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row End Stage Renal Disease Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 53. List of secondary sources, used in the study of Global End Stage Renal Disease Market
  • TABLE 54. List of primary sources, used in the study of Global End Stage Renal Disease Market
  • TABLE 55. Years considered for the study
  • TABLE 56. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global End Stage Renal Disease Market, research methodology
  • FIG 2. Global End Stage Renal Disease Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global End Stage Renal Disease Market, key trends 2021
  • FIG 5. Global End Stage Renal Disease Market, growth prospects 2022-2028
  • FIG 6. Global End Stage Renal Disease Market, porters 5 force model
  • FIG 7. Global End Stage Renal Disease Market, pest analysis
  • FIG 8. Global End Stage Renal Disease Market, value chain analysis
  • FIG 9. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global End Stage Renal Disease Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global End Stage Renal Disease Market, regional snapshot 2018 & 2028
  • FIG 15. North America End Stage Renal Disease Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe End Stage Renal Disease Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific End Stage Renal Disease Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America End Stage Renal Disease Market 2018 & 2028 (USD Billion)
  • FIG 19. Global End Stage Renal Disease Market, company market share analysis (2021)
目次

Global End Stage Renal Disease Market is valued approximately USD XX.X billion in 2021 and is anticipated to grow with a healthy growth rate of more than X.XX % over the forecast period 2022-2028. End Stage Renal Disease is a medical condition in which a person's kidneys cease functioning on a permanent basis leading to the need for a regular course of long-term dialysis or a kidney transplant to maintain life. The increasing prevalence of Diabetes and Hypertension has led the adoption of End Stage Renal Disease across the forecast period. For Instance: According to the IDF.Org approximately 537 million adults are living with diabetes as of 2020. Furthermore, the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Moreover, introduction of technologically advanced products would fuel the market of End Stage Renal Disease. Also, with the increasing number of hospitals and hospitals admissions for AKI is likely to increase the market growth during the forecast period. However, Stringent regulatory policies for dialysis products hinder the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global End Stage Renal Disease Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the dominating region across the world in terms of market share owing to increasing healthcare spending, various government initiatives & awareness campaigns regarding CKD, availability of technologically advanced products and the presence of newly-established state-of-the-art healthcare facilities in the region. Additionally, the enormous populace of diabetic and hypertension patients is required to help the development of the market in this region.

Major market players included in this report are:

Medtronic

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen AG

Baxter International Inc.

Asahi Kasei Medical Co., Ltd.

Cantel Medical

BD.

JMS Co. Ltd.

Nikkiso Co., Ltd.

Nipro Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

Transplant

Dialysis

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global End Stage Renal DiseaseMarket in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. End Stage Renal Disease Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. End Stage Renal Disease Market, by Treatment, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global End Stage Renal Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global End Stage Renal Disease Market Dynamics

  • 3.1. End Stage Renal Disease Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing Prevalence of Diabetes and Hypertension
      • 3.1.1.2. Introduction of Technologically advanced products
    • 3.1.2. Market Restraints
      • 3.1.2.1. Stringent Regulatory Policies for Dialysis products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing number of hospitals & hospital admissions for AKI

Chapter 4. Global End Stage Renal Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global End Stage Renal Disease Market, by Treatment

  • 6.1. Market Snapshot
  • 6.2. Global End Stage Renal Disease Market by Treatment, Performance - Potential Analysis
  • 6.3. Global End Stage Renal Disease Market Estimates & Forecasts by Treatment 2018-2028 (USD Billion)
  • 6.4. End Stage Renal Disease Market, Sub Segment Analysis
    • 6.4.1. Transplant
    • 6.4.2. Dialysis

Chapter 7. Global End Stage Renal Disease Market, Regional Analysis

  • 7.1. End Stage Renal Disease Market, Regional Market Snapshot
  • 7.2. North America End Stage Renal Disease Market
    • 7.2.1. U.S. End Stage Renal Disease Market
      • 7.2.1.1. Treatment breakdown estimates & forecasts, 2018-2028
    • 7.2.2. Canada End Stage Renal Disease Market
  • 7.3. Europe End Stage Renal Disease Market Snapshot
    • 7.3.1. U.K. End Stage Renal Disease Market
    • 7.3.2. Germany End Stage Renal Disease Market
    • 7.3.3. France End Stage Renal Disease Market
    • 7.3.4. Spain End Stage Renal Disease Market
    • 7.3.5. Italy End Stage Renal Disease Market
    • 7.3.6. Rest of Europe End Stage Renal Disease Market
  • 7.4. Asia-Pacific End Stage Renal Disease Market Snapshot
    • 7.4.1. China End Stage Renal Disease Market
    • 7.4.2. India End Stage Renal Disease Market
    • 7.4.3. Japan End Stage Renal Disease Market
    • 7.4.4. Australia End Stage Renal Disease Market
    • 7.4.5. South Korea End Stage Renal Disease Market
    • 7.4.6. Rest of Asia Pacific End Stage Renal Disease Market
  • 7.5. Latin America End Stage Renal Disease Market Snapshot
    • 7.5.1. Brazil End Stage Renal Disease Market
    • 7.5.2. Mexico End Stage Renal Disease Market
  • 7.6. Rest of The World End Stage Renal Disease Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Fresenius Medical Care AG & Co. KGaA
    • 8.2.3. B. Braun Melsungen AG
    • 8.2.4. Baxter International Inc.
    • 8.2.5. Asahi Kasei Medical Co., Ltd.
    • 8.2.6. Cantel Medical
    • 8.2.7. BD.
    • 8.2.8. JMS Co. Ltd.
    • 8.2.9. Nikkiso Co., Ltd.
    • 8.2.10. Nipro Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption